Full-Time

Contract – Clinical Research Scientist

Posted on 11/18/2024

Vedanta Biosciences

Vedanta Biosciences

51-200 employees

Develops microbiome-based therapies using bacteria

Biotechnology
Healthcare

Mid, Senior

Cambridge, MA, USA

Category
Public Health
Biology Lab & Research
Biology & Biotech
Required Skills
Google Cloud Platform
Requirements
  • Life sciences degree with a minimum of 4 to 6 years of relevant clinical, preclinical, and/or translational research experience in the pharmaceutical industry or healthcare setting. Advanced degree in life sciences (e.g., PharmD, PhD, MS, MPH) strongly preferred.
  • Educational and/or work experience in one or more of the following is desirable: microbiology, infectious diseases, allergic diseases, immunology, gastroenterology.
  • Experience in analysis and interpretation of clinical data (safety and efficacy) and a working knowledge of biostatistics, GCP, and regulatory requirements for clinical studies.
  • Ability to make independent, timely, and appropriate decisions.
  • Ability to work both independently and collaboratively in a fast-paced, team-based matrix environment.
  • Excellent written/verbal communication and presentation skills.
  • High level of organizational and project management skills.
  • Ability to adjust to multiple cross-program demands and shifting priorities; ability to meet day-to-day challenges with confidence and professionalism.
  • Experience interacting with development operations (clinical operations, regulatory, QA) and clinical investigators.
  • Travel to internal meetings, external meetings, and scientific conferences (up to 10%).
Responsibilities
  • Utilize your clinical/scientific expertise to develop and advance the clinical strategy of your programs.
  • Develop expertise in the diseases we are studying and the applications, mechanisms, and clinical endpoints for studies of microbiome-based therapeutics.
  • Contribute across multiple projects and therapeutic areas.
  • Participate in study management and project teams to attain clinical development goals and achievement of study metrics related to time, budget, and quality.
  • Address scientific questions that arise and ensure there is ongoing oversight of safety during the conduct of clinical studies.
  • Ensure high quality data in clinical studies through participation in routine medical monitoring of accruing data.
  • Maintain appropriate level of medical oversight of Contract Research Organizations and other clinical study vendors.
  • Contribute to the development of other study and program documents including informed consent forms, medical monitoring plans, Data Monitoring Committee charters, Annual Safety Reports, etc.
  • Work with medical and scientific staff to review, summarize, interpret, and present on the safety, efficacy, pharmacokinetic/pharmacodynamic and patient-reported outcomes of clinical studies.
  • In collaboration with a senior clinician, co-author clinical and regulatory documents including protocols; clinical study reports; Investigator’s Brochures; training documents; regulatory responses, briefing books and reporting requirements; and components of INDs and submission dossiers.
  • Contribute to the design and execution of organizational initiatives conducted in support of development programs.
  • Along with project teams and stakeholders, contribute to the organization, preparation, and execution of Investigator Meetings, Steering Committee Meetings, and Advisory Board meetings.
  • Remain up to date on current information regarding the competitive landscape, regulations, guidelines, and scientific advances in the relevant fields.
  • Cultivate relationships with external partners such as clinical investigators, members of Steering Committees, clinicians, and scientists in support of innovation and business development.

Vedanta Biosciences focuses on developing microbiome therapies using groups of beneficial bacteria known as bacterial consortia. These consortia can colonize the human intestine and have the potential to treat various diseases. The company utilizes a proprietary discovery platform to identify and assemble these bacteria into effective therapeutic teams. Unlike many competitors, Vedanta has achieved commercial-scale production of its drug candidates while adhering to strict FDA regulations for safety and quality. The goal of Vedanta Biosciences is to transform healthcare by providing new treatment options through its innovative approach to drug discovery.

Company Stage

N/A

Total Funding

$364.5M

Headquarters

Cambridge, Massachusetts

Founded

2010

Growth & Insights
Headcount

6 month growth

-4%

1 year growth

-3%

2 year growth

27%
Simplify Jobs

Simplify's Take

What believers are saying

  • The initiation of the Phase 3 RESTORATiVE303 study for VE303 marks a significant milestone, potentially leading to a first-in-class treatment for recurrent C. difficile infection.
  • Fast Track designation by the FDA for VE303 accelerates the development and review process, increasing the likelihood of timely market entry.
  • A recent $106.5 million financing round strengthens Vedanta's financial position, enabling further advancement of its pipeline and expansion of its innovative therapies.

What critics are saying

  • The success of Vedanta's therapies is highly dependent on the outcomes of clinical trials, which carry inherent uncertainties and risks.
  • The niche focus on bacterial consortia may limit market size and appeal compared to broader-spectrum microbiome therapies.

What makes Vedanta Biosciences unique

  • Vedanta Biosciences is pioneering the use of defined bacterial consortia for drug development, a novel approach that sets it apart from traditional microbiome therapies.
  • The company's proprietary discovery platform allows for the rational design of bacterial consortia, optimizing therapeutic activity and offering a unique competitive edge.
  • Vedanta is the first to achieve commercial-scale CGMP production of bacterial drug candidates, ensuring high-quality and regulatory-compliant products.

Help us improve and share your feedback! Did you find this helpful?